32 studies found for:    acorda
Show Display Options
Rank Status Study
1 Completed Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.
Condition: Multiple Sclerosis
Intervention: Drug: BIIB041 (Fampridine-SR)
2 Completed
Has Results
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR
3 Completed
Has Results
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR  b.i.d. (Twice Daily)
4 Completed
Has Results
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Condition: Ischemic Stroke
Interventions: Drug: placebo/dalfampridine-ER;   Drug: dalfampridine-ER/placebo
5 Completed
Has Results
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR
6 Active, not recruiting An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: rHIgM22
7 Recruiting A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure
Condition: Heart Failure
Interventions: Other: Placebo;   Drug: GGF2;   Drug: Midazolam
8 Completed
Has Results
Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
Condition: Renal Insufficiency
Intervention: Drug: Dalfampridine-ER
9 Completed
Has Results
Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Drug: Placebo
10 Completed
Has Results
Study of Oral Fampridine-SR in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Fampridine-SR;   Drug: Placebo
11 Enrolling by invitation A Study of AC105 in Patients With Acute Traumatic Spinal Cord Injury
Condition: Acute Spinal Cord Injury
Interventions: Drug: AC105;   Other: Placebo
12 Completed
Has Results
Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Condition: Cerebral Palsy (CP)
Interventions: Drug: dalfampridine-ER 10mg;   Other: Placebo
13 Terminated
Has Results
Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy
Condition: Spasticity Due to Cerebral Palsy
Intervention: Drug: Zanaflex Capsules
14 Completed
Has Results
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Drug: Fampridine-SR;   Drug: Placebo
15 Completed
Has Results
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Dalfampridine-ER 5mg;   Drug: Dalfampridine-ER 10mg;   Other: Placebo
16 Completed A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial
Condition: Spasticity
Interventions: Drug: Tizanidine;   Drug: Placebo crossover to moxifloxacin;   Drug: Moxifloxacin crossover to placebo
17 Completed
Has Results
Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure
Condition: Heart Failure
Interventions: Drug: Glial growth factor 2/ Neuregulin 1β3;   Other: Placebo
18 Completed
Has Results
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Other: Placebo
19 Completed A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode
Condition: Epilepsy
Intervention: Drug: Diazepam
20 Completed
Has Results
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Other: Withdrawal of dalfampridine-ER 10mg

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years